Search trials for
Showing NN of NN trials
Enrolling

Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants Wi...

The primary objective of the study is to evaluate the safety and tolerability of single-ascending intravenous (IV) infusions of BIIB076...

Enrolling

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia...

The purpose of this study is to assess the safety, tolerability, biomarker and cognitive efficacy of investigational products in subjects...

Enrolling

Addressing Dementia Via Agitation-Centered Evaluation

This is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of...

Enrolling

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disea...

The study will evaluate the effect of LY3002813 on brain scans. The study will evaluate the safety of LY3002813 by...

Enrolling

Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascendin...

This Phase I clinical study is a randomized, double-blind, placebo-controlled, parallel-design study to thoroughly assess the safety profile and PK...

Enrolling

A Study of RO7105705 in Patients With Moderate Alzheimer's Disease

This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the clinical efficacy, safety, pharmacokinetics, and pharmacodynamics of ...

Enrolling

European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LC...

Brain changes associated with Alzheimer's disease may precede symptoms of Alzheimer's Dementia by over 20 years. The Investigators hope to...

Enrolling

Study to Evaluate DNL747 in Subjects With Alzheimer's Disease

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral doses of DNL747...

Enrolling

Efficacy and Safety of MMFS in Mild AD

This study is designed to evaluate the safety and efficacy of MMFS for improving cognition and global function in patients...

Enrolling

A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alz...

This study will be conducted to evaluate the efficacy of BAN2401 in participants with early Alzheimer's disease (EAD) by determining...

Enrolling

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated...

To evaluate the safety of brexpiprazole 1 mg or 2 mg after a 14 week treatment regimen for agitation associated...

Enrolling

Brexpiprazole for the Treatment of Patients With Agitation Associated With Demen...

To evaluate the superiority of brexpiprazole 1 mg or 2 mg over placebo after a 10-week treatment regimen for agitation...